Lung cancer comes in two main types: non-small cell and small cell. Each has different patterns, growth rates, and treatment needs. Smoking is the top risk factor, but…
Kidney cancer affects over 80,000 Americans annually, with renal cell carcinoma as the dominant type. Benjamin R. Lee, MD, MBA, outlines current AUA guideline recommendations, including when to…
NEW YORK (Reuters Health) – Breast cancer recurrence rates are lower with aromatase inhibitors than with tamoxifen, according to meta-analyses published online by the Journal of Clinical Oncology.…
NEW YORK (Reuters Health) – Children who are disease-free 5 years after a cancer diagnosis are still at risk for recurrence for another 20 years or more, new…
NEW YORK (Reuters Health) – Abatacept, an agent that modifies the costimulatory signal required for T-cell activation, does not increase malignancy rates in patients with rheumatoid arthritis (RA),…
NEW YORK (Reuters Health) – Methadone is a safe, effective first- or second-line treatment of cancer pain, even in outpatients, a retrospective study suggests. Concerns over its long…
NEW YORK (Reuters Health) – For men with hot flushes from androgen suppression for prostate cancer, medroxyprogesterone appears to be the best option for relief, according to a…
NEW YORK (Reuters Health) – New research suggests that high-dose vitamin D can be safely given to breast cancer patients with bone metastases, but it will not affect…
NEW YORK (Reuters Health) – In treating patients with metastatic melanoma, thalidomide plus temozolomide is no better than temozolomide or dacarbazine alone, according to a report in the…
NEW YORK (Reuters Health) – For a palpable breast mass with benign features on ultrasound, short-term follow-up is a reasonable alternative to immediate biopsy, particularly in a young…
NEW YORK (Reuters Health) – New research suggests that when noncalcified lung nodules are detected by computed tomography (CT), assessment of their volume and volume-doubling time with repeat…
NEW YORK (Reuters Health) – Adding cetuximab to standard chemotherapy for colorectal liver metastases often shrinks inoperable lesions enough to permit resection, according to a study released today…